Home » Topics » BioWorld Science

BioWorld Science
RSS

Didanosine + hydroxyurea effective in reducing HIV viral load

April 19, 1996

Ciba-Geigy selects CGP-61755 for development

April 19, 1996

Canada, Brazil approve Invirase for marketing

April 19, 1996

HIV protease inhibitors described by Hoechst Marion Roussel

April 19, 1996

VP-63843 effective in phase II

April 19, 1996

Sankyo claims HIV protease inhibitors

April 19, 1996

Bayer claims anti-HIV quinolone carboxylic acids

April 19, 1996

DepoAmikacin phase I trial completed

April 19, 1996

Abelcet trial results in children favorable

April 19, 1996

Cefdinir close to filing in U.S.

April 19, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 7, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 7, 2024.
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...
Sanofi bets on Resalis’ oligonucleotide RES-010 for obesity
BioWorld
After missing out on the glucagon-like peptide 1 obesity market, Sanofi SA is prospecting for next-generation drugs and is making a strategic equity investment in...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.